Axon Therapies
New York, US · Founded 2014
Founders & leadership
PS
Paul S. LaVioletteDirector
HR
Howard R. LevinExecutive Officer, Director
MR
Mark R. GelfandExecutive Officer
MS
Mitchell S. BloomExecutive Officer
Reported raises · per SEC filings
Form D private placements$7.5MraisedFeb 2019 · 10 investors · Other Technology
Rule 506(b)$1.3MraisedJun 2017 · 7 investors · Other Technology
Rule 506(b)$2MraisedApr 2016 · 1 investors · Other Technology
Rule 506(b)Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.